baber/WOPTO huggingface dataset:
Patent AU-2017201331-A1 (AU)
Title: Chopping Module
Inventor: BERTINO LUIZ HENRIQUE
IPC: A01D41/14
Filed: 2017-02-27
Abstract: CHOPPING MODULE, developed with means to catch and pull the plants by pushing them between a rotating cutting set and chopping them into billets, which comprises a case-shaped body (1) with three open sides, a front inlet (2) for plants to be chopped, a rear outlet (3) for chopped plants and a lower outlet (4) for residues; plants are pulled by two crosswise pairs of rotating pulling rollers for the plants to be chopped (5a) and (5b), after which the set of fixed shearbar (6) is assembled crosswise, which upper side is aligned to the diameters of the lower stationary pulling rollers (5a), wherein, between those and the upper floating pulling rollers (5b), it forms a passageway (7) for the plants to be chopped and, after the fixed shearbar (6), said passageway continues in the form of a slide (8) sloping downwards to the outlet (3) for chopped plants and also a crosswise rotating cut device (9), located above the slide (7) and next to the fixed shearbar (6). 9-1 5b 5a 4FIG. 4
Patent AU-2017202150-A1 (AU)
Title: Antibody drug conjugates and corresponding antibodies
Inventor: ETTENBERG SETH
IPC: C07K16/28
Filed: 2017-03-31
Abstract: H:\dar\Interwoven\NRPortbl\DCC\DAR\13591581 .doex-30/03/2017 The present invention relates to anti-FGFR2 and FGFR4 antibodies, antibody fragments, antibody drug conjugates, and their uses for the treatment of cancer.
Patent AU-2017202957-A1 (AU)
Title: Human antibodies and diagnostic and therapeutic uses thereof for the treatment of neurological disease
Inventor: RODRIGUEZ MOSES
IPC: A61K39/395
Filed: 2017-05-03
Abstract: Specific binding members, particularly human antibodies, particularly recombinant antibodies, and fragments thereof, which are capable of binding to and recognizing neurons in the CNS and eliciting responses in CNS neurons are provided. The antibodies are useful for neuroprotection and in the diagnosis and treatment of conditions associated with nerve damage, injury or degeneration and neurodegenerative disease. The antibodies, variable regions or CDR domain sequences thereof, and fragments thereof of the invention may also be used in therapy in combination with chemotherapeutics, immune modulators, or neuroactive agents and/or with other antibodies or fragments thereof. Antibodies are exemplified by the antibodies IgM12 and IgM42 whose sequences are provided herein.
Patent AU-2017204395-A1 (AU)
Title: Method for preparing a composition comprising highly concentrated antibodies by ultrafiltration
Inventor: LAU KELBY
IPC: B01D61/14
Filed: 2017-06-28
Abstract: METHOD FOR PREPARING A COMPOSITION COMPRISING HIGHLY CONCENTRATED ANTIBODIES BY ULTRAFILTRATION The present invention provides a method for preparing a composition comprising highly concentrated antibodies by ultrafiltration in batch concentration mode having a first constant feed rate step and a second controlled feed rate step.
Patent AU-2017204784-A1 (AU)
Title: Compositions and methods for controlling infestation
Inventor: BOWLES VERNON MORRISON
IPC: A01N43/40
Filed: 2017-07-12
Abstract: Riszp\j tnovnNRorbiD C SZP1175910_1.doc-I2/07/20 7 The present invention is directed to methods of treating pest infestation by inhibiting metabolic processes of the pest such as for example, processes involved in invertebrate 5 remodelling.
Patent AU-2017227808-A1 (AU)
Title: Two-stage gasifier and gasification process with feedstock flexibility
Inventor: WILLIAMS CHANCELOR L
IPC: C10J3/46
Filed: 2017-03-02
Abstract: A gasification process may include (a) introducing a liquid hydrocarbon feedstock and at least one of a dry feedstock or a first slurried feedstock into a reactor lower section, wherein the at least one dry feedstock or first slurried feedstock is introduced through two primary feed nozzles while the liquid hydrocarbon feedstock is introduced through at least two secondary feed nozzles; (b) partially combusting the feedstocks in the reactor lower section with a gas stream comprising an oxygen-containing gas or steam to evolve heat and form products comprising hot synthesis gas; (c) passing said hot synthesis gas from step (b) upward into a reactor upper section; (d) and introducing a second slurried feedstock into said reactor upper section, whereby heat from said hot synthesis gas supports reaction of the second slurried feedstock by pyrolysis and gasification reactions.
Patent AU-2017232546-A1 (AU)
Title: Engineered immunoglobulins with altered FCRN binding
Inventor: FOSS STIAN
IPC: C07K16/08
Filed: 2017-03-14
Abstract: The present invention relates to compositions and methods for antibody-mediated therapy. In particular, provided herein are engineered immunoglobulins with altered half-life.
Patent AU-2017234388-A1 (AU)
Title: Ironing board with interconnection with a remote iron
Inventor: MILANESE PIER ANTONIO
IPC: D06F81/08
Filed: 2017-03-14
Abstract: Ironing board comprising a unitized body (1), supported by legs adjustable in height (4) and provided with a bored plane (2) covered by a breathable cloth (3), and comprising an electrical supply cable (16) for the ironing board, which is connectable to the electrical supply line, for supplying the various electrical components of the ironing board, a motorized fan (5) supported into the unitized body (1) and adapted to suck and blow the vapour, at least an electrical heating resistance (6) for the bored plane (2), at least a regulating thermostat (7) for the heating temperature of the plane, a control board (8) including the switch for turning on the board (12), a switch (13) for the suction/blowing ventilation, a pushbutton (14) for switching on the ventilation automatically, and comprising also at least a remote vapour iron separated from the ironing board, constituted by an iron (30) supplied with vapour by a boiler vapour generator (31) or by an iron (32) generating the vapour in the chamber of its own plate by introducing the water from the tank (33) inside the unitized body (1) with at least an electronic card (9) composed by various electronic components and by at least a radio receiver device (17); in said remote iron (30 or 32) at least a remote control is installed consisting in a remote control body (18) comprising an electronic card (20) with motion sensors (21), and a radio pulse transmitter (23), suitable to transmit or not transmit radio pulses to said radio receiver device (17), a pushbutton for reversing (22) the ventilation direction from suction to blowing and vice versa, a rechargeable battery (24), a USB plug (25) to recharge the remote control, and a fixed base body for the remote control (19).
Patent AU-2017271458-A1 (AU)
Title: New crystalline form of N-[5-(3,5-difluoro-benzyl)-1H-indazol-3-yl]-4-(4-methyl-piperazin-1-yl)-2-(tetrahydro-pyran-4-ylamino)-benzamide
Inventor: CANDIANI ILARIA
IPC: C07D405/12
Filed: 2017-05-18
Abstract: The present invention relates to a new crystalline form of N-[5-(3,5-difluoro-benzyl)-1H-indazol-3-yl]-4-(4-methyl-piperazin-1-yl)-2-(tetrahydro-pyran-4-ylamino)-benzamide, process for its preparation, its utility in treating diseases caused by deregulated protein kinase activity and pharmaceutical compositions containing it.
Patent AU-2017282459-A1 (AU)
Title: Cationic lipid
Inventor: SUZUKI YUTA
IPC: C07D241/04
Filed: 2017-06-22
Abstract: The present invention provides a cationic lipid which is able to be used for nucleic acid delivery to the cytoplasm. A cationic lipid according to the present invention is, for example, a compound represented by formula (1a) or a pharmaceutically acceptable salt thereof. (In formula (1a), each of L
Patent AU-2017286864-A1 (AU)
Title: Nicotine particles and compositions
Inventor: ZUBER GERARD
IPC: A61L9/16
Filed: 2017-06-14
Abstract: The composition is formed of a plurality of particles. These particles include nicotine, a sugar, and an amino acid or short peptide.
Patent AU-2017294549-A1 (AU)
Title: Adrenomedullin for assessing congestion in a subject with acute heart failure
Inventor: BERGMANN ANDREAS
IPC: G01N33/68
Filed: 2017-07-07
Abstract: Subject matter of the present invention is a method for a) diagnosing congestion or assessing or monitoring the extent of congestion in a subject or, b) predicting or determining or monitoring need of therapy or intervention or predicting or determining or monitoring the success of a therapy or intervention of congestion or guiding a therapy or intervention in a subject or, c) predicting decongestion or residual congestion after therapy or intervention of congestion in a subject or, d) assessing decongestion or residual congestion after therapy or intervention of congestion in a subject or, e) assessing the decision on hospital discharge of a subject, wherein said subject is subject having acute heart failure that is either new-onset AHF or acute decompensated HF or acute decompensated chronic HF or wherein said subject is a subject having chronic heart failure with worsening signs/symptoms of chronic heart failure and wherein Pro-Adrenomedullin or fragments thereof of at least 5 amino acids is used as an early surrogate marker for congestion.
Patent AU-2017306243-A1 (AU)
Title: Electronic device and method for outputting thumbnail corresponding to user input
Inventor: JUNG YU MIN
IPC: G06F17/30
Filed: 2017-07-07
Abstract: An electronic device includes a display, a processor and a memory that stores an image file having image data. The image data includes at least one object and metadata. The metadata includes information about an area corresponding to the at least one object and identification information of the at least one object. The processor outputs the area of the image file, which includes the identification information corresponding to a user input as a thumbnail of the image file, in the display in response to the user input.
Patent AU-2017315321-A1 (AU)
Title: Cholesteryl ester vesicles loading peptides, proteins and nucleic acids into chylomicrons and body cells
Inventor: SCHENTAG JEROME J
IPC: A61P35/00
Filed: 2017-08-23
Abstract: The present invention is directed to one or more macromolecules in a lipid vesicle oral formulation which targets intracellular receptors, in particular for peptides, proteins, nucleic acids and mixtures thereof, optionally in combination with small molecules. The invention encapsulates said macromolecules in a neutral lipid vesicle comprised of one or more cholesteryl esters. Unique properties of macromolecules encapsulated in said vesicles include high oral bioavailability, defined herein as in at least 50%, i.e., often in excess of 50% on the basis of oral to parenteral AUC. Non-limiting examples are provided, for large hydrophilic molecules such as peptides, proteins and nucleic acids which heretofore have been very poorly absorbed by the mammalian intestine. In prior art; said molecules are generally less than 25% bioavailable, even with protective coatings and optionally absorption enhancing component substances in the formulation. An additional feature of the present invention is high tissue concentrations after oral use, a result of rapid uptake of cholestosomes delivered by chylomicrons to body cells. A preferred embodiment is disclosed for insulin, where with eholestosome encapsulation oral bioavailability is at least 66%. Prior to the present invention, oral bioavailability of insulin and other peptides and proteins was maximally 25% and usually between 5% and 10%. Additional preferred examples are provided for one or more macromolecules useful in the treatment of cancer and in particular intracellular targeting in the practice of cancer immunotherapeutics.
Patent AU-2017316513-A1 (AU)
Title: Method of preventing acute attacks of hereditary angioedema associated with C1 esterase inhibitor deficiency
Inventor: MACHNIG THOMAS
IPC: A61K38/57
Filed: 2017-08-23
Abstract: The invention relates to a method for determining a dosing scheme for the treatment of hereditary angioedema and/or the prevention of hereditary angioedema attacks with C1 esterase inhibitor to optimize treatment response in an individual patient. Accordingly, the present invention provides means for determining individual C1 esterase inhibitor dosing schemes that result in an optimal treatment/prevention outcome.
Patent AU-2017333548-A1 (AU)
Title: Method for synthesizing novel chiral ligand, metal chelate, a variety of non-natural amino acids, maraviroc and key intermediate thereof
Inventor: LIU HONG
IPC: C07C227/34
Filed: 2017-09-19
Abstract: Disclosed is a method for synthesizing a novel chiral ligand, a metal chelate, a variety of non-natural amino acids, Maraviroc and a key intermediate thereof. In the invention, (R)-2-methyl proline is selected and used as a starting raw material, (S)-β
Patent AU-2018203253-A1 (AU)
Title: Patient Pad for Operating Theatre
Inventor: COPELAND JOHN ROBERT
IPC: A23L29/20
Filed: 2018-05-10
Abstract: A disposable gel pad for cushioning the plate of an operating table's patient support apparatus is a block of gel with one face of the block adapted to locate the pad on the plate. Usually the 5 pad will be enclosed in a film envelope. A pocket in the envelope allows the pad to engage the plate. Stick on patches which provide a pocket and sacroiliac pads are variants. Sacroiliac pads can be cast with a soft gel front for patient contact joined to a hard gel rear for screw or bayonet fixing to the patient support apparatus.
Patent AU-2018203713-A1 (AU)
Title: Histidine engineered light chain antibodies and genetically modified non-human animals for generating the same
Inventor: MCWHIRTER JOHN
IPC: A01K67/027
Filed: 2018-05-25
Abstract: A genetically modified non-human animal is provided, wherein the non-human animal expresses an antibody repertoire capable of pH dependent binding to antigens upon immunization. A genetically modified non-human animal is provided that expresses a single light chain variable domain derived from a single rearranged light chain variable region gene in the germline of the non-human animal, wherein the single rearranged light chain variable region gene comprises a substitution of at least one non-histidine encoding codon with a histidine encoding codon. Methods of making non-human animals that express antibodies comprising a histidine-containing universal light chain are provided.
Patent AU-2018211533-A1 (AU)
Title: Method and system for transmitting alternative image content of a physical display to different viewers
Inventor: BOLL HANS-PETER
IPC: H04N21/2343
Filed: 2018-01-29
Abstract: The present invention relates to a method and a system for transmitting alternative image content of a physical display to different viewers, comprising: generating at least two different sets of image data, each set of image data comprising a sequence of individual images; displaying the images of said at least two sets of image data in a time-sliced multiplexed manner on said physical display; generating at least one video stream of a scene which includes said physical display, said video stream consisting of video frames captured synchronously with the displaying of the images of one of said at least two sets of image data on said physical display; and transmitting said video stream to a sub-set of said viewers,wherein at least one set of image data comprises a sequence of images and inverse images. The present invention also relates to a control interface implementing the claimed method.
Patent AU-2018220119-A1 (AU)
Title: Protection circuit, oscillation compensation circuit and power supply circuit in solid state pulse modulator
Inventor: LIU YAOHONG
IPC: H03K3/57
Filed: 2018-08-24
Abstract: The present disclosure provides a gate protection circuit for an Insulated Gate Bipolar Transistor (IGBT), the IGBT being used as a switch device in a solid state pulse modulator based on the MARX generator principle, the gate protection circuit including: a voltage regulator configured to supply a stable voltage to an emitter of the IGBT with respect to the ground for a gate of the IGBT. 1002 1001 1002 10011 10021 1001 1002 1001 -1002 1004 F-I 103 1003 1003 1003 Fig.I1 +24V ---T T_ Fig. 2
Patent AU-2018235866-A1 (AU)
Title: System and method for modifying a wireless communication object
Inventor: SMITH GAVIN
IPC: G06Q20/32
Filed: 2018-03-14
Abstract: Systems and methods for modifying a wireless communication object during transit. One method includes transmitting, by a loop antenna within a first reader at a first location within a transit system, an interrogation signal to the wireless communication object. The wireless communication object may receive the interrogation signal, modulate an electromagnetic wireless signal with information identifying the electromagnetic wireless object, and transit the electromagnetic wireless signal. The first reader may receive, using the loop antenna, the electromagnetic wireless signal at a first time and a first tap of the wireless communication object may be registered. In response to registering the first tap, a first amount of units on the wireless communication object may be held as unavailable. For each passage of a predetermined amount of time after the first time, a virtual tap of the wireless communication object may be registered at an update time.
Patent AU-2018253177-A1 (AU)
Title: Maintaining page interaction functionality with overlay content
Inventor: ROGER GWENDOLINE
IPC: G06Q30/02
Filed: 2018-04-12
Abstract: Systems and methods are described for dynamically presenting overlay content on portions of an image or video within a page or other user interface, while allowing at least partial user interactivity with the underlying image or video. Overlay content may be displayed within a container object that is placed over the underlying page image or video. The visible overlay content may be smaller than and/or differently shaped than the container object (such as by not being rectangular and/or by the overlay content including transparent portions), such that some of the underlying image or video remains visible beneath the overlay content and the container. When a user selection is made within the container object, the responsive action to be performed by the client computing device may be either an action identified in the original page code or an action associated with the overlay content, depending on location of the selection.
Patent AU-2018263784-A1 (AU)
Title: In-body perfusion system
Inventor: ANDRETTA CARLO
IPC: A61F2/02
Filed: 2018-05-02
Abstract: An implantable perfusion device (2) comprises a tubular transmission line (4) with an inlet end (6), an outlet end (8) and a flow restriction element (10) located therebetween, whereby an inlet section (12) of the transmission line is defined between the inlet end and the flow restriction element and whereby an outlet section (14) of the transmission line is defined between the flow restriction element and the outlet end. Moreover, the device comprises a perfusion chamber (16) containing a load of biologically active cells and is provided with a fluid entrance (18), a fluid exit (20) and a chamber volume (22) formed therebetween. The fluid entrance comprises at least one first microchannel platelet (24) and the fluid exit comprises at least one second microchannel platelet (26), each one of the microchannel platelets comprising at least one array of microchannels (28) defining a fluid passage between respective external and internal platelet faces, the microchannels having an opening of 0.2 to 10 μm. The fluid entrance (18) of the perfusion chamber is in fluid communication with the inlet section (12) of the transmission line; and the flow restriction element (10) is configured to establish a predetermined pressure excess in the inlet section (12) versus the outlet section (14).
Patent AU-2018264745-A1 (AU)
Title: Methods of producing cultivar swards with tailored properties
Inventor: EADY COLIN CHARLES
IPC: A01N63/30
Filed: 2018-05-08
Abstract: The art surrounding endophytes and cultivar combinations is largely restricted to single cultivar and endophyte combinations. In the rare situations where more than one endophyte is present, this has been an unintended outcome. A focus on single endophytes and a search for an ideal endophyte to date has only resulted in non-ideal situations where the ability of the inoculated cultivar to withstand abiotic or biotic stress or not cause animal health issues is compromised. Methods are described herein for producing a sward, the sward comprising a first amount of cultivar inoculated with or already comprising a first endophyte and a further amount of the same cultivar inoculated with or already comprising a further endophyte, the sward having a predetermined or designed for aggregate alkaloid concentration. The sward is designed for, can be multiplied and can be designed in a predetermined manner to suit the abiotic and biotic stresses of a particular environment and animal health requirements.
Patent AU-2018273106-A1 (AU)
Title: Methods and systems for removing carbon dioxide
Inventor: KREYMANN BERNHARD
IPC: A61M1/28
Filed: 2018-05-22
Abstract: Systems and methods suitable for extracorporeal lung support are provided that expose blood, across a semipermeable membrane, to a dialysis liquid. The dialysis liquid features a buffering agent and has a high buffering capacity for H+ ions. Carbon dioxide, bicarbonate and hydrogen cations are transported across a semipermeable membrane into the dialysis liquid. The dialysis fluid may be recycled and repeatedly used, and its pH may be adjusted, and other fluids added to it. Certain substances may be removed from the blood, and the amount of these substances removed from the blood may be substantially automatically or substantially continuously monitored or quantified. The systems and methods are suitable for treating or preventing respiratory acidosis, metabolic acidosis, and diseases featuring lung malfunction, kidney malfunction, or liver malfunction.
Patent AU-2018282348-A1 (AU)
Title: Compositions and methods
Inventor: MCKENZIE GREGORY
IPC: A01N65/00
Filed: 2018-12-19
Abstract: Disclosed herein are therapeutic compositions containing non-pathogenic, germination-competent bacterial spores, for the prevention, control, and treatment of gastrointestinal diseases, disorders and conditions and for general nutritional health.
Patent AU-2018317857-A1 (AU)
Title: 6-amino-7,9-dihydro-8h-purin-8-one derivatives as toll-like receptor 7 (TLR7) agonists as immunostimulants
Inventor: POUDEL YAM B
IPC: A61P37/04
Filed: 2018-08-16
Abstract: Compounds having a structure according to formula (I). where R
Patent AU-2018323613-A1 (AU)
Title: Reduction of advanced glycation endproducts from bodily fluids
Inventor: SIMM ANDREAS VIKTOR
IPC: G01N1/10
Filed: 2018-08-30
Abstract: The invention concerns removing advanced glycation end products from a bodily fluid by contacting the bodily fluid with a sorbent.
Patent AU-2018327188-A1 (AU)
Title: Kaempferol analog-containing composition
Inventor: IKEDA YASUTAKA
IPC: A61P21/00
Filed: 2018-08-30
Abstract: The present invention provides an exercise efficiency-improving composition, a fatigue-reducing composition, and a dynamic visual acuity-improving composition characterized by containing a kaempferol analog.
Patent AU-2018341921-A1 (AU)
Title: Use of extended surfactants in process membrane cleaning
Inventor: SCHACHT PAUL FRAZER
IPC: B01D65/06
Filed: 2018-09-05
Abstract: Disclosed are membrane separation cleaning processes and clean in place compositions for such membranes. The cleaning compositions can remove proteins, fats, and other food, beverage, and brewery based soils and offer an environmentally friendly alternative surfactant system to NPE. Branched extended chain PO/EO nonionic surfactants with certain characteristics may be used to provide superior cleaning to membranes. The specific surfactants may be used alone or in combination. In some embodiments, the surfactant package is used as part of a cleaning composition.